Free Trial

Icon (ICLR) Competitors

Icon logo
$150.06 -0.77 (-0.51%)
Closing price 01:48 PM Eastern
Extended Trading
$150.06 0.00 (0.00%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ICLR vs. MEDP, CRL, IQV, TCOM, RDDT, GIB, CPAY, TOST, AER, and GRAB

Should you be buying Icon stock or one of its competitors? The main competitors of Icon include Medpace (MEDP), Charles River Laboratories International (CRL), IQVIA (IQV), Trip.com Group (TCOM), Reddit (RDDT), CGI Group (GIB), Corpay (CPAY), Toast (TOST), Aercap (AER), and Grab (GRAB).

Icon vs. Its Competitors

Medpace (NASDAQ:MEDP) and Icon (NASDAQ:ICLR) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Medpace has a net margin of 19.31% compared to Icon's net margin of 9.25%. Medpace's return on equity of 54.36% beat Icon's return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace19.31% 54.36% 20.81%
Icon 9.25%11.46%6.49%

Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.11B4.38$404.39M$13.1024.54
Icon$8.19B1.48$791.47M$9.1816.35

78.0% of Medpace shares are held by institutional investors. Comparatively, 95.6% of Icon shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 44.0% of Icon shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Medpace presently has a consensus target price of $344.82, indicating a potential upside of 7.25%. Icon has a consensus target price of $213.08, indicating a potential upside of 42.00%. Given Icon's stronger consensus rating and higher probable upside, analysts clearly believe Icon is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
0 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.21
Icon
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.60

In the previous week, Medpace and Medpace both had 6 articles in the media. Medpace's average media sentiment score of 0.73 beat Icon's score of 0.36 indicating that Medpace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Icon
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Medpace has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500.

Summary

Medpace and Icon tied by winning 8 of the 16 factors compared between the two stocks.

Get Icon News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICLR vs. The Competition

MetricIconMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$12.12B$7.31B$5.49B$9.01B
Dividend YieldN/A2.77%5.39%4.09%
P/E Ratio16.3527.9427.4320.06
Price / Sales1.4832.39398.25108.31
Price / Cash7.4321.4136.1356.90
Price / Book1.276.698.085.67
Net Income$791.47M$233.06M$3.16B$248.47M
7 Day Performance2.25%2.20%2.12%2.90%
1 Month Performance12.18%4.93%4.43%5.75%
1 Year Performance-52.81%35.84%35.62%21.36%

Icon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICLR
Icon
4.3889 of 5 stars
$150.06
-0.5%
$213.08
+42.0%
-52.6%$12.12B$8.19B16.3541,900
MEDP
Medpace
4.5353 of 5 stars
$313.86
+1.0%
$344.82
+9.9%
-19.4%$9.02B$2.16B23.965,900
CRL
Charles River Laboratories International
4.0647 of 5 stars
$151.64
+1.1%
$171.85
+13.3%
-21.8%$7.45B$4.05B-233.2920,100
IQV
IQVIA
4.914 of 5 stars
$157.69
+0.1%
$226.32
+43.5%
-20.6%$27.28B$15.41B21.4886,000
TCOM
Trip.com Group
4.9223 of 5 stars
$58.64
-0.1%
$77.25
+31.7%
+23.9%$38.31B$7.30B17.0033,700
RDDT
Reddit
2.2929 of 5 stars
$150.74
+5.4%
$139.57
-7.4%
+116.7%$27.81B$1.30B255.502,233Trending News
Analyst Forecast
Insider Trade
GIB
CGI Group
3.9063 of 5 stars
$104.93
+1.5%
$156.75
+49.4%
+3.8%$23.55B$10.79B19.1190,000Positive News
CPAY
Corpay
3.9562 of 5 stars
$332.07
+1.5%
$401.86
+21.0%
+25.8%$23.41B$3.97B23.2910,500Positive News
Analyst Upgrade
TOST
Toast
2.9338 of 5 stars
$44.33
+1.0%
$41.21
-7.0%
+63.7%$22.08B$4.96B192.744,500Positive News
AER
Aercap
2.5844 of 5 stars
$116.96
-0.2%
$119.25
+2.0%
+22.1%$21.85B$8.06B10.38740Gap Up
GRAB
Grab
1.8279 of 5 stars
$5.03
+2.2%
$5.71
+13.4%
+40.0%$20.26B$2.80B251.639,490

Related Companies and Tools


This page (NASDAQ:ICLR) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners